Schulz, H.;                     Schmoeckel, E.;                     Kuhn, C.;                     Hofmann, S.;                     Mayr, D.;                     Mahner, S.;                     Jeschke, U.    
        Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients. Int. J. Mol. Sci. 2017, 18, 1230.
    https://doi.org/10.3390/ijms18061230
    AMA Style
    
                                Schulz H,                                 Schmoeckel E,                                 Kuhn C,                                 Hofmann S,                                 Mayr D,                                 Mahner S,                                 Jeschke U.        
                Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients. International Journal of Molecular Sciences. 2017; 18(6):1230.
        https://doi.org/10.3390/ijms18061230
    
    Chicago/Turabian Style
    
                                Schulz, Heiko,                                 Elisa Schmoeckel,                                 Christina Kuhn,                                 Simone Hofmann,                                 Doris Mayr,                                 Sven Mahner,                                 and Udo Jeschke.        
                2017. "Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients" International Journal of Molecular Sciences 18, no. 6: 1230.
        https://doi.org/10.3390/ijms18061230
    
    APA Style
    
                                Schulz, H.,                                 Schmoeckel, E.,                                 Kuhn, C.,                                 Hofmann, S.,                                 Mayr, D.,                                 Mahner, S.,                                 & Jeschke, U.        
        
        (2017). Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients. International Journal of Molecular Sciences, 18(6), 1230.
        https://doi.org/10.3390/ijms18061230